In the liver, the combined dysregulation of the Hippo and PI3K/Akt pathways accelerates nonalcoholic fatty liver disease (NAFLD) and tumorigenesis [95]. The gene discussed is AKT1; the disease is metabolic dysfunction-associated steatotic liver disease.